Skip to content

Efficacy of Navaka Kashaya and Manjisthadi Tail in the management of dry eczema.

A randomised controlled clinical trial on efficacy of Navaka Kashaya and Manjisthadi Tail in the management of Vicharchika with special reference to dry eczema

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054863
Enrollment
40
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Sponsors

NATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients age between 18-60 years Patients of either sex Patients having any signs and symptoms of Vicharchika (Eczema) like Vaivarnyata (Discolouration) Rukshata (Dryness) Kandu (pruritis) Rajii (Thickening of skin) Patients having chronicity less than 5 years

Exclusion criteria

Exclusion criteria: Patients with Steroid and cytotoxic treatment( >5 years). Patient having concomitant illness( like-HIV, Malignancy, any immuno-compromised state.) patient having associated skin disease like-vitiligo, psoriasis etc.) Pregnant or lactating women Patient participated in any clinical trial for last 6 months.

Design outcomes

Primary

MeasureTime frame
Change in the EASI ScoreTimepoint: 42 Days

Secondary

MeasureTime frame
Change in Sign and Symptoms of Vicharchika with special reference to Dry Eczema and Change in the Extent of impairment in QoL by using DLQI(Dermatology Life Quality Index). Timepoint: Baseline and 42 days after treatment.

Countries

India

Contacts

Public ContactDr Puja Agarwal

National Institute of Ayurveda Deemed to be University

hari_mohan68@yahoo.co.in9461297017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026